Andere talen Renovaro Inc. Börse Stuttgart

Aandelen

2Q5

US29350E1047

Vertraagde tijd Börse Stuttgart Andere beurzen 08:13:41 01-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,592 ^EUR	+16,89%		+11,09%	-49,30%

14/06	Renovaro zegt dat investeerders $10 miljoen extra aandelen hebben toegezegd	MT
24/05	Renovaro, Amsterdam UMC Kankercentrum van plan om joint venture te vormen voor kankerimmunotherapie	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Renovaro Says Investors Commit $10 Million Additional Equity	14/06
Renovaro, Inc. Announces $10 million in Equity Committed	14/06
Renovaro Inc. announced that it has received $9.455942 million in funding	14/06
Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy	24/05
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy	24/05
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy	24/05
Renovaro Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	15/05
Renovaro : Material Event - Form 8-K	02/05
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics	30/04
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics	30/04
RENOVARO - RENOVAROCUBE TO ACQUIRE 100% OWNERSHIP OF CYCLOMICS, REINFORCING CUTTING-EDGE CANCER DIAGNOSTICS PARTNERSHIP	25/04
Renovaro's RenovaroCube Amends Agreement to Acquire 100% Stake in Cyclomics	24/04
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership	24/04
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care	18/04
Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board	18/04
Renovaro Inc. Appoints Simon Tarsh as Interim Chief Financial Officer	13/03
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	12/03
Renovaro Inc. Announces Resignation of Luisa Puche as Chief Financial Officer, Effective as of March 21, 2024	05/03
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	03/03
ROSEN, LEADING INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB	25/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Renovaro Inc. Börse Stuttgart

Aandelen

2Q5

US29350E1047

Andere talen

Filters